An open-label, single-arm trial to assess the shedding, immunogenicity, and safety of FluMist [influenza virus vaccine live] administered to healthy individuals 5-49 years of age

Trial Profile

An open-label, single-arm trial to assess the shedding, immunogenicity, and safety of FluMist [influenza virus vaccine live] administered to healthy individuals 5-49 years of age

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2007

At a glance

  • Drugs Influenza virus vaccine live (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors MedImmune
  • Most Recent Events

    • 09 Nov 2007 Status changed from in progress to completed
    • 12 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top